-
Product Insights
New![]()
Mainit-Sadanga Geothermal Plant
Mainit-Sadanga Geothermal Plant is a geothermal project located in Cordillera Administrative Region, Philippines. The project is owned and being developed by PRC-Magma Energy Resources Inc. The project is at the permitting stage. Empower your strategies with our Mainit-Sadanga Geothermal Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of...
-
Product Insights
New![]()
Buguias-Tinoc Geothermal Project
Buguias-Tinoc Geothermal Project is a geothermal project located in Cordillera Administrative Region, Philippines. The project is owned and being developed by PRC-Magma Energy Resources Inc. The project is at the permitting stage. Empower your strategies with our Buguias-Tinoc Geothermal Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of...
-
Analyst Opinions
![]()
Generative Artificial Intelligence (AI) Powerplay: What’s in the Big Tech AI Playbook
Accessing the in-depth insight from the ‘Generative AI Powerplay’ report will offer you: Innovation Insights: Presents real-world innovation examples related to the generative AI products, models, hardware, and infrastructure by major technology companies across sectors. An understaning on how big tech companies are innovating in the generative AI space to gain competitive advantage. How is the 'Generative AI Powerplay' report different from other reports in the market? The report demonstrates how the major tech companies, primarily MAGMA, are competing for dominance...
-
Sector Analysis
![]()
Contract Small Molecule API Manufacturing Industry by the Numbers – 2021 Edition
According to the Global Data’s Drugs database, it indicates that maximum of the marketed drugs is found to be small molecules, despite many of the prominent contract manufacturing organizations (CMOs) investing in advanced therapy medicinal product (ATMP) capabilities in recent years and an increasing use of biologic APIs in both the pipeline and among marketed drugs. With the increase in high potency small molecule APIs, has been driven by the rise of oncology pipeline drugs coupled with small or virtual...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.